Table 1.
Pearson correlations between the SD NRS and SSD-derived sleep parameters in the ARCADIA 1 (NCT03985943) and ARCADIA 2 (NCT03989349) trials
| Sleep parametera | Baseline SD NRS score | Change in SD NRS score from baseline to week 8 | Change in SD NRS score from baseline to week 16 | |||
|---|---|---|---|---|---|---|
| ARCADIA 1 | ARCADIA 2 | ARCADIA 1 | ARCADIA 2 | ARCADIA 1 | ARCADIA 2 | |
| SOL | 0.267*** | 0.338*** | 0.258*** | 0.173*** | 0.248*** | 0.198*** |
| WASO | 0.403*** | 0.385*** | 0.445*** | 0.373*** | 0.488*** | 0.276*** |
| TWASO | −0.001 | 0.056 | −0.009 | 0.051 | −0.013 | 0.056 |
| TWT | 0.376*** | 0.418*** | 0.390*** | 0.349*** | 0.412*** | 0.320*** |
| TIB | 0.007 | 0.112** | −0.080* | 0.013 | −0.043 | 0.006 |
| TST | −0.270*** | −0.245*** | −0.341*** | 0.259*** | −0.338*** | −0.243*** |
| SE | −0.430*** | −0.433*** | −0.449*** | −0.374*** | −0.482*** | −0.380*** |
| NWASO-AD | 0.409*** | 0.400*** | 0.487*** | 0.416*** | 0.506*** | 0.378*** |
| WASO-AD | 0.460*** | 0.441*** | 0.485*** | 0.426*** | 0.509*** | 0.366*** |
| SQR | −0.660*** | −0.666*** | −0.637*** | −0.619*** | −0.648*** | −0.604*** |
| NDS-AD | – | 0.153*** | – | 0.089* | – | 0.097* |
| NDS-AD nap | 0.156*** | – | 0.083* | – | 0.081* | – |
| NDS-AD doze off | 0.111** | – | 0.047 | – | 0.055 | – |
| DS-AD total duration | – | 0.115** | – | 0.081 | – | 0.097* |
| DS-AD total nap duration | 0.131*** | – | 0.062 | – | 0.105* | – |
| DS-AD total doze off duration | 0.078* | – | 0.077* | – | 0.103* | – |
AD (related to) atopic dermatitis, DS daytime sleepiness, NDS number of times of daytime sleepiness, NWASO number of times of WASO, SE sleep efficiency, SOL sleep onset latency, SQR sleep quality/refresh, TIB time in bed, TST total sleep time, TWASO terminal wakefulness after sleep onset, TWT total awake time, WASO wakefulness after sleep onset
aSSD-derived sleep parameters were assessed at the same time points as the SD NRS
*p < 0.05, **p < 0.01, ***p < 0.001